Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3897-3904.
Prepublished online as a Blood First Edition Paper on January 29, 2004; DOI 10.1182/blood-2003-11-4026.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-4026v1
103/10/3897    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, X.
Right arrow Articles by Eaves, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, X.
Right arrow Articles by Eaves, C.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted November 25, 2003
Accepted January 18, 2004

Deregulated Expression in Ph+ Human Leukemias of AHI-1, a Gene Activated by Insertional Mutagenesis in Mouse Models of Leukemia

Xiaoyan Jiang*, Yun Zhao, Wing Yiu Chan, Suzanne Vercauteren, Emily Pang, Sean Kennedy, Frank Nicolini, Allen Eaves, and Connie Eaves

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Hematology Department, Hospital E. Herriot, Lyon, France
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Departments of Medicine, Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Departments of Medicine, Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

* Corresponding author; email: xjiang{at}bccancer.bc.ca.

Ahi-1/AHI-1 encodes a family of protein isoforms containing one SH3 domain and multiple WD40-repeat domains. The function of these proteins is unknown but involvement in leukemogenesis has been suggested by the high frequency of Ahi-1 mutations seen in certain virus-induced murine leukemias. Here we show that in both mice and humans, Ahi-1/AHI-1 expression is highest in the most primitive hematopoietic cells with specific patterns of down-regulation in different lineages. Cells from patients with chronic myeloid leukemia (n=28) show elevated AHI-1 transcripts in all disease phases and, in chronic phase, in the leukemic cells at all stages of differentiation, including quiescent (G0) CD34+ cells as well as terminally differentiating cells. In the most primitive lin--CD34+CD38- CML cells, transcripts for the 2 shorter isoforms of AHI-1 are also increased. Although 15 of 16 human lymphoid and myeloid leukemic cell lines showed aberrant control of AHI-1 expression, this was not seen in blasts obtained directly from patients with acute Ph- leukemia (n=15). Taken together, our results suggest that down-regulation of AHI-1 expression is an important conserved step in primitive normal hematopoietic cell differentiation and that perturbations in AHI-1 expression may contribute to the development of specific types of human leukemia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

TEL-AML1 and BCR-ABL: different leukemias, similar questions
Linda Stork
Blood 2004 103: 3611-3612. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J AndrolHome page
B. K. Han, J. G. Jung, J. Nam, J. K. Moon, J. N. Kim, S. I. Lee, J. K. Kim, H. Kim, and J. Y. Han
Identification of the Major Proteins Produced by Cultured Germline Stem Cells in Chicken
J Androl, November 1, 2009; 30(6): 690 - 702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Kennah, A. Ringrose, L. L. Zhou, S. Esmailzadeh, H. Qian, M.-w. Su, Y. Zhou, and X. Jiang
Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells
Blood, May 7, 2009; 113(19): 4646 - 4655.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. L. Zhou, Y. Zhao, A. Ringrose, D. DeGeer, E. Kennah, A. E.-J. Lin, G. Sheng, X.-J. Li, A. Turhan, and X. Jiang
AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
J. Exp. Med., October 27, 2008; 205(11): 2657 - 2671.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Clappier, W. Cuccuini, A. Kalota, A. Crinquette, J.-M. Cayuela, W. A. Dik, A. W. Langerak, B. Montpellier, B. Nadel, P. Walrafen, et al.
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children
Blood, August 15, 2007; 110(4): 1251 - 1261.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Jin, Y. Yamazaki, M. Takuwa, T. Takahara, K. Kaneko, T. Kuwata, S. Miyata, and T. Nakamura
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Blood, May 1, 2007; 109(9): 3998 - 4005.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. G. Jorgensen, M. Copland, E. K. Allan, X. Jiang, A. Eaves, C. Eaves, and T. L. Holyoake
Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor In vitro Promotes their Elimination by Imatinib Mesylate
Clin. Cancer Res., January 15, 2006; 12(2): 626 - 633.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020